Mylan was offered a 6% stake in Biocon after the Biocon Biologics deal, in which Biocon had acquired all of Mylan’s stake in the Biologics unit in January this year through a share swap and cash.
Mylan was offered a 6% stake in Biocon after the Biocon Biologics deal, in which Biocon had acquired all of Mylan’s stake in the Biologics unit in January this year through a share swap and cash.